Botulinum toxin type A in the treatment of patients with cervical dystonia

References

• FahnSBressmanSBMarsdenCDClassification of dystoniaAdv Neurol1998781109750897
   PubMedGoogle Scholar
• BrashearAThe botulinum toxins in the treatment of cervical dystoniaSemin Neurol2001211
   Web of Science ®Google Scholar
• JankovicJLederSWarnerDSchwartzKCervical dystonia: clinical findings and associated movement disordersNeurology1991417108810912067638
   PubMed Web of Science ®Google Scholar
• NuttJGMuenterMDMeltonLJIIIAronsonAKurlandLTEpidemiology of dystonia in Rochester, Minnesota 5Adv Neurol1988503613653400496
   PubMedGoogle Scholar
• GeyerHLBressmanSBThe diagnosis of dystonia 2Lancet Neurol20065978079016914406
   PubMed Web of Science ®Google Scholar
• JankovicJBrinMFBotulinum toxin: historical perspective and potential new indicationsMuscle Nerve Suppl199764551295145
   Google Scholar
• BressmanSBDystonia updateClin Neuropharmacol200023523925111154091
   PubMed Web of Science ®Google Scholar
• WardABMolenaersGColosimoCBerardelliAClinical value of botulinum toxin in neurological indicationsEur J Neurol200613 Suppl 4202617112346
   PubMed Web of Science ®Google Scholar
• DuvoisinRCSpasmodic torticollis: the role of surgical denervationMayo Clin Proc19916644334352013994
   PubMed Web of Science ®Google Scholar
• BraunVRichterHPSelective peripheral denervation for spasmodic torticollis: 13-year experience with 155 patientsJ Neurosurg200297Suppl 220721212296680
   PubMed Web of Science ®Google Scholar
• HungSWHamaniCLozanoAMLong-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia 10Neurology200768645745917283323
   PubMed Web of Science ®Google Scholar
• KupschABeneckeRMullerJPallidal deep-brain stimulation in primary generalized or segmental dystonia 2N Engl J Med2006355191978199017093249
   PubMed Web of Science ®Google Scholar
• BrinMFLewMFAdlerCHSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaNeurology19995371431143810534247
   PubMed Web of Science ®Google Scholar
• BrashearALewMFDykstraDDSafety and efficacy of Neuro-Bloc (botulinum toxin type B) in type A-responsive cervical dystonia 8Neurology19995371439144610534248
   PubMed Web of Science ®Google Scholar
• SimpsonDMBlitzerABrashearAAssessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology 3Neurology200870191699170618458230
   PubMed Web of Science ®Google Scholar
• ScottABMagoonEHMcNeerKWStagerDRBotulinum treatment of strabismus in childrenTrans Am Ophthalmol Soc198987174802562519
   PubMedGoogle Scholar
• GreenePFahnSDiamondBDevelopment of resistance to botulinum toxin type A in patients with torticollisMov Disord1994922132178196686
   PubMed Web of Science ®Google Scholar
• JankovicJSchwartzKBotulinum toxin injections for cervical dystoniaNeurology19904022772802300249
   PubMed Web of Science ®Google Scholar
• LewMFAdornatoBTDuaneDDBotulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia 3Neurology19974937017079305326
   PubMed Web of Science ®Google Scholar
• GreenePEFahnSUse of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type AMov Disord1993844794838232357
   PubMed Web of Science ®Google Scholar
• HouserMKSheeanGLLeesAJFurther studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type AJ Neurol Neurosurg Psychiatry19986455775809598669
   PubMed Web of Science ®Google Scholar
• DasguptaBRBerryLJBoroffDAPurification of Clostridium botulinum type A toxinBiochim Biophys Acta19702142
   Google Scholar
• BrinMFComellaCLJankovicJLaiFNaumannMLong-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay 1Mov Disord200823101353136018546321
   PubMed Web of Science ®Google Scholar
• BrinMFBotulinum toxin: chemistry, pharmacology, toxicity, and immunologyMuscle Nerve Suppl1997668S146S1489826987
   PubMedGoogle Scholar
• BlackieJDLeesAJBotulinum toxin treatment in spasmodic torticollisJ Neurol Neurosurg Psychiatry19905386406432213040
   PubMed Web of Science ®Google Scholar
• BrashearAClinical comparisons of botulinum neurotoxin formulations 1Neurologist200814528929818784598
   PubMed Web of Science ®Google Scholar
• XiaoAYWeiLXiaSRothmanSYuSPIonic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neuronsJ Neurosci20022241350136211850462
   PubMed Web of Science ®Google Scholar
• BrinMFAokiK RogerMayerNSDBotulinum toxin Type A: PharmacologyNew YorkWeMove2002110124
   Google Scholar
• BurgenASDickensFZatmanLJThe action of botulinum toxin on the neuro-muscular junction 1J Physiol19491091–2102415394302
   PubMed Web of Science ®Google Scholar
• SetlerPETherapeutic use of botulinum toxins: background and history 1Clin J Pain200218Suppl 6S119S12412569958
   PubMed Web of Science ®Google Scholar
• SetlerPThe biochemistry of botulinum toxin type B 2Neurology200055 12Suppl 5S222811188981
   PubMed Web of Science ®Google Scholar
• ComellaCLJankovicJShannonKMComparison of botulinum toxin serotypes A and B for the treatment of cervical dystoniaNeurology20056591423142916275831
   PubMed Web of Science ®Google Scholar
• BrinMFComellaCLJankovicJLaiFNaumannMLong-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay 1Mov Disord200823101353136018546321
   PubMed Web of Science ®Google Scholar
• TruongDDuaneDDJankovicJEfficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled studyMov Disord200520778379115736159
   PubMed Web of Science ®Google Scholar
• HannaPAJankovicJMouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical responseNeurology1998506162416299633703
   PubMed Web of Science ®Google Scholar
• HannaPAJankovicJVincentAComparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodiesJ Neurol Neurosurg Psychiatry199966561261610209172
   PubMed Web of Science ®Google Scholar
• HamjianJAWalkerFOSerial neurophysiological studies of intramuscular botulinum-A toxin in humansMuscle Nerve19941712138513927969239
   PubMed Web of Science ®Google Scholar
• JankovicJVuongKDAhsanJComparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystoniaNeurology2003607
   Web of Science ®Google Scholar
• JankovicJHunterCDolimbekBZClinico-immunologic aspects of botulinum toxin type B treatment of cervical dystoniaNeurology200667122233223517190952
   PubMed Web of Science ®Google Scholar
• DresslerDMunchauABhatiaKPQuinnNPBigalkeHAntibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses?Eur Neurol200247210812111844899
   PubMed Web of Science ®Google Scholar
• AllerganIPackage Insert, BOTOX (Botulinum toxin Type A Purified Neurotoxin Complex) 2000Irvine Allergan Inc2000
   Google Scholar
• Elan Pharmaceuticals IPackage Insert Myobloc Botulinum toxin type B injectable solution 2000South San FranciscoElan2000
   Google Scholar
• BeneckeRJostWHKanovskyPRuzickaEComesGGrafeSA new botulinum toxin type A free of complexing proteins for treatment of cervical dystoniaNeurology200564111949195115955951
   PubMed Web of Science ®Google Scholar
• ScottABKraftSPBotulinum toxin injection in the management of lateral rectus paresisOphthalmology19859256766834011142
   PubMed Web of Science ®Google Scholar
• O’BrienCBrashearACullisPCervical dystonia severity scale reliability study 9Mov Disord20011661086109011748739
   PubMed Web of Science ®Google Scholar
• AdlerCHKumarRPharmacological and surgical options for the treatment of cervical dystoniaNeurology20005512S9S1411188983
   PubMed Web of Science ®Google Scholar
• BrashearAThe safety and tolerability of botulinum toxins for the treatment of cervical dystoniaExpert Opin Drug Saf200542
   Google Scholar
• GelbDJLowensteinDHAminoffMJControlled trial of botulinum toxin injections in the treatment of spasmodic torticollisNeurology198939180842642616
   PubMed Web of Science ®Google Scholar
• BrashearABerganKWojcieszekJSiemersERAmbrosiusWPatients’ perception of stopping or continuing treatment of cervical dystonia with botulinum toxin type AMov Disord200015115015410634256
   PubMed Web of Science ®Google Scholar
• HaussermannPMarczochSKlingerCLandgrebeMConradBCeballos-BaumannALong-term follow-up of cervical dystonia patients treated with botulinum toxin AMov Disord200419330330815022184
   PubMed Web of Science ®Google Scholar
• WisselJKanovskyPRuzickaEEfficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group studyJ Neurol2001248121073107812013585
   PubMed Web of Science ®Google Scholar
• PoeweWDeuschlGNebeAWhat is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study GroupJ Neurol Neurosurg Psychiatry19986411379436721
   PubMed Web of Science ®Google Scholar
• BransJWAramidehMKoelmanJHLindeboomRSpeelmanJDOngerboer de VisserBWElectromyography in cervical dystonia: changes after botulinum and trihexyphenidylNeurology19985138158189748032
   PubMed Web of Science ®Google Scholar
• RanouxDGuryCFondaraiJMasJLZuberMRespective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystoniaJ Neurol Neurosurg Psychiatry200272445946211909903
   PubMed Web of Science ®Google Scholar
• OdergrenTHjaltasonHKaakkolaSA double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia 3J Neurol Neurosurg Psychiatry19986416129436720
   PubMed Web of Science ®Google Scholar
• ComellaCLBuchmanASTannerCMBrown-TomsNCGoetzCGBotulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistanceNeurology19924248788821565246
   PubMed Web of Science ®Google Scholar
• GreenePKangUFahnSBrinMMoskowitzCFlasterEDouble-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollisNeurology1990408121312182199847
   PubMed Web of Science ®Google Scholar
• BransJWLindeboomRSnoekJWBotulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trialNeurology19964641066728780093
   PubMed Web of Science ®Google Scholar
• BrashearABlitzerATreatment of Cervical Dystonia with Botulinum Toxin151227 6-1-0004 ElsevierOperative Techniques in Otolaryngology Head and Neck Surgery Friedman Michael
   Google Scholar